Safety, feasibility and effectiveness of first in‐human administration of muscle‐derived stem/progenitor cells modified with connexin‐43 gene for treatment of advanced chronic heart failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety, feasibility and effectiveness of first in‐human administration of muscle‐derived stem/progenitor cells modified with connexin‐43 gene for treatment of advanced chronic heart failure

Published:2017-01 Issue:1 Volume:19 Page:148-157
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Gwizdala Adrian¹,Rozwadowska Natalia²,Kolanowski Tomasz Jan²,Malcher Agnieszka²,Cieplucha Aleksandra¹,Perek Bartlomiej³,Seniuk Wojciech¹,Straburzynska‐Migaj Ewa¹,Oko‐Sarnowska Zofia¹,Cholewinski Witold⁴,Michalak Michal⁵,Grajek Stefan¹,Kurpisz Maciej²

Affiliation:

1. Poznan University of Medical Sciences 1st Department of Cardiology Poznan Poland

2. Department of Reproductive Biology and Stem Cells Institute of Human Genetics Polish Academy of Sciences, ul. Strzeszynska 32 60‐479 Poznan Poland

3. Poznan University of Medical Sciences Department of Cardiac Surgery Poznan Poland

4. Greater Poland Cancer Centre, Nuclear Medicine Department Poznan Poland

5. Poznan University of Medical Sciences Department of Statistics Poznan Poland

Funder

Narodowe Centrum Badań i Rozwoju

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.700

Reference34 articles.

1. Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation

2. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

3. Intramyocardial Injection of Autologous Cardiospheres or Cardiosphere-Derived Cells Preserves Function and Minimizes Adverse Ventricular Remodeling in Pigs With Heart Failure Post-Myocardial Infarction

4. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction

5. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem cell therapy for heart failure in the clinics: new perspectives in the era of precision medicine and artificial intelligence;Frontiers in Physiology;2024-01-09

2. Myogenic Cardiac Regeneration: Clinical Studies Using Skeletal Myoblasts;Handbook of Stem Cell Applications;2024

3. Stem Cell-based Therapies in Cardiovascular Diseases: From Pathophysiology to Clinical Outcomes;Current Pharmaceutical Design;2023-10

4. Stem cell-based therapies for heart failure management: a narrative review of current evidence and future perspectives;Heart Failure Reviews;2023-09-21

5. An Approach That Brings Out the Potential of Regenerative Therapies in Heart Failure;Circulation Journal;2023-03-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3